Biomarkers for Acute Graft-versus-host Disease
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 29, 2014
Trial Information
Current as of May 05, 2025
Unknown status
Keywords
ClinConnect Summary
Description of the project: The main objective of this prospective biological single center study (non interventional) is to identify non invasive biomarkers able to diagnose acute GVHD and/or predict outcome of patients with acute GVHD. The primary objective of the study is double: (1): to evaluate markers as diagnostic markers of GVHD (2): to evaluate the potential of the markers as risk factor for steroid-refractory acute GVHD occurrence. Secondary objectives are: -to evaluate the markers as risk factors for GVHD -to evaluate the potential of these markers as prognostic factors of 6-mont...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients receiving an allogeneic transplant
- • informed consent signed
- Exclusion Criteria:
- • patient refusal
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Marie Robin
Principal Investigator
Hôpital Saint-Louis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials